Neurology® Podcast

Latest Episodes:

January 24 2012 Issue Jan 24, 2012

Show notes

1) AB load and cognition and 2) Topic of the month: Ethics Issues. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Alberto Espay interviews Dr. Kejal Kantarci about her paper on AB load and cognition in cognitively normal older adults. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about Vespers curse. In the next part of the podcast Dr. Thomas Cochrane interviews Dr. Joseph Fins about neuroimaging in disorders of consciousness. Next week you will hear our last interview regarding ethic issues. The participants had nothing to disclose except Drs. Espay, Kantarci, Clardy, Cochrane and Fins.Dr. Kantarci receives research support from the NIH.Dr. Espay serves on scientific advisory boards for Boehringer Ingelheim and Solvay Pharmaceuticals, Inc.; serves on the editorial advisory board for The European Neurological Journal; has received speaker honoraria from UCB/SCHWARZ PHARMA, Medtronic, Inc., and Novartis; has received honoraria from Novartis, the American Academy of Neurology, and the Movement Disorders Society; has served on speakers' bureaus for UCB/SCHWARZ PHARMA and Novartis; receives/has received research support from Medtronic, Inc., Allergan, Inc., CleveMed, the KL2 Research Scholars mentored career development award, and NIH Institutional Clinical and Translational Science Award (RR026315-02), Dean Scholar's Award - University of Cincinnati, Davis Phinney Foundation, and the Michael J Fox Foundation. Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Cochrane received royalties from the publication of the book First Aid for the Boards: Neurology.Dr. Fins serves as an editorial board member for The Oncologist and The Cambridge Quarterly, received royalties from the publication of the book A Palliative Ethic of Care: Clinical Wisdom at Life's End and serves as President of American Society for Bioethics and Humanities.

January 17 2012 Issue Jan 17, 2012

Show notes

1) MuSK myasthenia and 2) Topic of the month: Ethics Issues. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Isabel Illa about her paper on the effect of rituximab in MuSK myasthenia. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about Möbius syndrome. In the next part of the podcast Dr. Nandini Muralidharan interviews Dr. Michael Schneck about conflicting values in withdrawal of support. Over the next two weeks, we will have additional interviews regarding ethic issues. The participants had nothing to disclose except Drs. Burns, Illa, Clardy and Schneck.Dr. Illa has received funding for travel from Genzyme Corporation; serves on the editorial board of Neurologia; is listed as author on patent(s) re: Dysferlin detection in monocytes licensed to Athena Diagnostics, Inc.; and receives research support from Grifols, FIS (Fondo de Investigaciones Sanitarias), ISCIII, Ministry of Health (Spain), and Fundacion Gemio. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Schneck serves on data safety monitoring boards for Talecris Biotherapeutics, Chelsea Therapeutics, and Baxter International Inc.; serves on the editorial advisory boards for the Journal of Stroke and Cerebrovascular Disease and Frontiers in Neurocritical Care and Neurohospitalist Care; receives publishing royalties from Continuum; serves on the speakers' bureaus for Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Boehringer Ingelheim, and Pfizer Inc; and receives research support from NMT Medical, Schering-Plough Corp., and the NIH.

January 10 2012 Issue Jan 10, 2012

Show notes

1) MRI cortical thickness biomarker and 2) Topic of the month: Ethics Issues. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Dr. Brad Dickerson about his paper on the MRI cortical thickness biomarker. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about the empty delta sign. In the next part of the podcast Dr. Alberto Espay interviews Dr. Tony Lang about placebo use for psychgenic disorders. Over the next three weeks, we will have additional interviews regarding ethic issues. The participants had nothing to disclose except Drs. Dickerson, Clardy, Espay and Lang.Dr. Dickerson serves on the editorial board of Hippocampus; serves as a consultant for Pfizer Inc; and receives research support from the NIH and the Alzheimer's Association.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Espay serves/has served on scientific advisory boards for Boehringer Ingelheim, Solvay Pharmaceuticals, Inc., and Abbott; has received honoraria from Novartis, the American Academy of Neurology, and the Movement Disorders Society; serves on the editorial board of The European Neurological Journal; serves/has served on the speakers' bureaus for Novartis and UCB; and receives/has received research support from Medtronic, Inc., Allergan, Inc., CleveMed, the University of Cincinnati, the Davis Phinney Foundation, and the Michael J Fox Foundation, and is funded by the KL2 Research Scholars mentored career development award, the NIH Institutional Clinical and Translational Science Award (RR026315-02). Dr. Lang has served on scientific advisory boards for Abbott, Allon Therapeutics, Inc., Biovail Corporation, Boerhinger Ingelheim, Cephalon, Inc., Ceregene, Eisai Inc., Medtronic, Inc. Lundbeck Inc., NeuroMolecular Pharmaceuticals , Novartis, Merck Serono, Solvay Pharmaceuticals, Inc., TaroPharma, and Teva Pharmaceutical Industries Ltd.; has received speaker honoraria from GlaxoSmithKline and UCB; receives/has received research support from the Canadian Institutes of Health Research, the Dystonia Medical Research Foundation, the Michael J. Fox Foundation, the National Parkinson Foundation, and the Ontario Problem Gambling Research Centre; and has served as an expert witness in cases related to the welding industry.

January 3 2012 Issue Jan 03, 2012

Show notes

1) Hemispatial neglect and 2) Topic of the month: Ethics Issues. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Giacomo Koch about his paper on hemispatial neglect. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about the trunk-thigh test of Babinski. In the next part of the podcast Dr. Farrah Mateen interviews Dr. Neelum Aggarwal about emerging issues at the intersection of neurology and applied ethics. Next week, Dr. Espay will interview Dr. Lang about placebo use for psychogenic disorders. The participants had nothing to disclose except Drs. Clardy, Mateen and Aggarwal.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Mateen served on the editorial team for the Neurology® Resident and Fellow Section from 2006 to 2009. Dr. Aggarwal has served on a scientific advisory board for Pfizer Inc; and receives research support from the NIH and the Alzheimer's Association.

Delayed Recall - January 2012 Jan 01, 2012

Show notes

Bedside Testing of the Prefrontal Lobes with interviews with Russ Swerdlow.

December 13 2011 Issue Dec 13, 2011

Show notes

1) Transverse myelitis and 2) Topic of the month: Dizziness. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Alex Bragg interviews Dr. Thomas Scott about the evidence-based guideline on transverse myelitis. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about Gates' rule of 4 of the brainstem. In the next part of the podcast Dr. Ted Burns interviews Drs. Kevin Kerber and Robert W. Baloh about Dix-Hallpike maneuver. The participants had nothing to disclose except Drs. Scott, Clardy, Burns, Kerber and Baloh.Dr. Scott has received funding for travel or speaker honoraria from, served on the speakers' bureaus and scientific advisory boards of, and performed consultation work for Acorda Therapeutics Inc., Avanir Pharmaceuticals, Biogen Idec, Novartis, and Teva Pharmaceutical Industries Ltd.; served as an associate editor for BMC Neurology; and has received research support from Biogen Idec, National Multiple Sclerosis Society, Novartis, Pittsburgh Foundation, and Teva Pharmaceutical Industries Ltd.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Kerber has served as a consultant for and received speaker honoraria from the American Academy of Neurology; receives publishing royalties for Clinical Neurophysiology of the Vestibular System, 4th edition (Oxford University Press, 2010); and receives research support from the NIH/NCRR and the Agency for Healthcare Research and Quality.Dr. Baloh has received speaker honoraria from the American Academy of Neurology; serves on the editorial board of Neurology; receives publishing royalties for Clinical Neurophysiology of the Vestibular System, 4th edition (Oxford University Press, 2010); and receives research support from the NIH.

Delayed Recall - December 2011 Dec 01, 2011

Show notes

Update on stroke care. Interviews with Brett Kissela from the summer of 2011.

November 29 2011 Issue Nov 28, 2011

Show notes

1) Respective epilepsy surgery and 2) Topic of the month: Hypoxic-ischemic encephalopathy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Howard Goodkin interviews Dr. Hamada Hamid about his paper on respective epilepsy surgery. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about Post-measles central nervous system syndromes. In the next part of the podcast Dr. Ted Burns interviews Dr. Eelco Wijdicks about renal insufficiency with final comments on the monthly topic: hypoxic-ischemic encephalopathy. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Goodkin, Hamid, Fugate, Burns and Wijdicks.Dr. Goodkin serves on the scientific board for Tuberous Sclerosis Alliance and CURE; serves on the editorial board for Neurology and Surgical Neurology International; receives royalties from the publication of the book The choking game and other strangulation activities in children and adolescents; and is funded by NIH grants [R01 NS067439 PI and R01 NS48413 PI].Dr. Hamid serves as Managing Editor of the Journal of Muslim Mental Health and receives research support from the National EpiFellows Foundation and the Epilepsy Foundation. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Wijdicks serves as Editor-in-Chief for Neurocritical Care; and receives royalties for books published by Oxford University Press.

November 22 2011 Issue Nov 21, 2011

Show notes

1) Practice of Neurology 2000-2010 Report and 2) Topic of the month: Hypoxic-ischemic encephalopathy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Ms. Oksana Drogan about the Practice of Neurology 2000-2010 Report. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about Ice Pack Test. In the next part of the podcast Dr. Ted Burns interviews Dr. Eelco Wijdicks about imaging and laboratory testing. For the last week, Dr. Burns will interview Dr. Wijdicks about take-home comments on the monthly topic. The participants had nothing to disclose except Ms. Drogan and Drs. Burns, Fugate, and Wijdicks.Ms. Drogan is a salaried employee of the American Academy of Neurology.Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Wijdicks serves as Editor-in-Chief for Neurocritical Care; and receives royalties for books published by Oxford University Press.

November 15 2011 Issue Nov 15, 2011

Show notes

1) Intravenous dihydroergotamine and 2) Topic of the month: Hypoxic-ischemic encephalopathy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Pearce Korb interviews Dr. Peter Goadsby about his paper on intravenous dihydroergotamine. In the next segment, Dr. Jennifer Fugate is reading our e-Pearl of the week about Figure 4 sign. In the next part of the podcast Dr. Ted Burns interviews Dr. Eelco Wijdicks about myoclonic status. Over the following weeks, Dr. Burns will interview Dr. Wijdicks about imaging plus laboratory testing and take-home comments from topic discussed. The participants had nothing to disclose except Drs. Goadsby, Fugate, Burns and Wijdicks.Dr. Goadsby has served as a consultant for or served on a scientific advisory board for Advanced Bionics, Allergan, Inc., Almirall, Amgen, ATI, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Boston Scientific, CoLucid Pharmaceuticals, Coherex Medical, Inc., Eli Lilly & Company, GlaxoSmithKline, Johnson & Johnson, Medtronic, Inc., MAP Pharmaceuticals, Inc. (makers of an inhaled form of DHE; this consultation period post-dates the period of audit, the period of data collection and initial analysis), Minster Pharmaceuticals plc, Merck & Co., Inc., Neuralieve Inc., NeurAxon Inc., NeuroTherapeutics Pharma, and Pfizer Inc.; receives royalties from the publication of Mechanism and Management of Headache, 7th ed. (Elsevier, 2005); and has received research support from GlaxoSmithKline, Neuralieve Inc., Merck & Co., Inc., Johnson & Johnson, and MAP Pharmaceuticals, Inc. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (30% effort); and has received research support from the Myasthenia Gravis Foundation of America and Knopp Neurosciences Inc..Dr. Wijdicks serves as Editor-in-Chief for Neurocritical Care; and receives royalties for books published by Oxford University Press.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected